About Shenzhen JYMed Technology
Located in the cosmetic labs in China hub of Shenzhen’s Biomedicine Innovation Industrial Park, Shenzhen JYMed Technology operates advanced facilities for peptide manufacturing and pharmaceutical development. The company maintains:
- A state-of-the-art R&D center in Shenzhen with modern peptide synthesizers
- Two FDA-inspected production facilities in Shenzhen and Hubei
- Multi-ton scale production capabilities with up to 99% purity
- A portfolio of 20+ peptide APIs with FDA DMF registration
With 570 employees and management bringing 20+ years of industry expertise, JYMed serves the pharmaceutical and cosmetic sectors from its strategic location in China’s Greater Bay Area innovation zone.
Frequently asked questions
Shenzhen JYMed Technology operates in the following areas:
- Peptide API Manufacturing
- Production of 20+ peptide APIs
- Scale options from mg to kg quantities
- Purity ranges from crude to >99%
- Product Portfolio
- Semaglutide
- Tirzepatide
- Liraglutide
- Degarelix
- Oxytocin
- Production Standards
- Non-GMP grade
- GMP-compliant manufacturing
- FDA DMF registered products
| Category | Capabilities |
|---|---|
| Manufacturing Scale |
|
| Quality Control |
|
| Technical Resources |
|
The company operates three facilities in China:
- Research Center
- Location: Shenzhen
- Focus: R&D operations
- Equipment: Peptide synthesizers and analytical instruments
- Production Facilities
- Shenzhen facility
- Hubei facility with FDA inspection clearance
- Multi-ton scale production capability
More details about Shenzhen JYMed Technology
A leading peptide technology company in Shenzhen
Shenzhen JYMed Technology, established in 2009, has grown into a significant player in the field of peptide manufacturing. With 570 employees and a management team bringing over two decades of industry expertise, the company maintains high standards in pharmaceutical development.
Research and development capabilities
Operating as both a cosmetic lab and pharmaceutical research facility, JYMed’s research center in Shenzhen is equipped with state-of-the-art peptide synthesizers and analytical instruments. The company’s dedication to innovation has led to the development of over 20 peptide APIs, including Semaglutide and Oxytocin.
Production facilities and standards
Manufacturing excellence
The company operates two production facilities – one in Shenzhen and another in Hubei. These facilities enable production ranging from milligram to kilogram quantities, with purity levels reaching up to 99%. The Hubei facility recently passed FDA inspection and received GMP compliance certification.
Quality assurance
JYMed’s commitment to quality is evidenced by its successful FDA DMF registrations for five products. The company adheres to strict regulatory compliance standards across all its operations.
Strategic location and market presence
Based in the Biomedicine Innovation Industrial Park in Shenzhen’s Pingshan District, JYMed benefits from the region’s advanced pharmaceutical infrastructure. This location positions the company within China’s thriving biopharmaceutical manufacturing sector, enabling efficient distribution across Asian markets.
Services and capabilities
- Custom peptide synthesis and development
- API production at various scales
- Regulatory documentation support
- Quality control and analytical testing
- Process development and optimization
Company gallery
